![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07K 16/28 | (2006.01) |
C07K 16/46 | (2006.01) | ||
C07K 16/44 | (2006.01) | ||
A61K 39/395 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 3472207 |
(13) | Kind of document | T |
(96) | European patent application number | 17752291.9 |
Date of filing the European patent application | 2017-06-20 | |
(97) | Date of publication of the European application | 2019-04-24 |
(45) | Date of publication and mention of the grant of the patent | 2021-01-20 |
(46) | Date of publication of the claims translation | 2021-05-10 |
(86) | Number | PCT/EP2017/065073 |
Date | 2017-06-20 |
(87) | Number | WO 2017/220569 |
Date | 2017-12-28 |
(30) | Number | Date | Country code |
201662352482 P | 2016-06-20 | US |
(72) |
CAMPBELL, Jamie, GB
SANDY, Nikole, GB
TUNA, Mihriban, GB
WOLLERTON VAN HORCK, Francisca, GB
EVERETT, Katy Louise, GB
GASPAR, Miguel, GB
KRAMAN, Matthew, GB
KMIECIK, Katarzyna, GB
FAROUDI, Mustapha, GB
FOSH, Natalie, GB
HEBEIS, Barbara, GB
|
(73) |
F-star Therapeutics Limited ,
Eddeva B920, Babraham Research Campus, Cambridge, CB22 3AT,
GB
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Surišančios molekulės, kurios suriša PD-L1 ir LAG-3 |
BINDING MOLECULES BINDING PD-L1 AND LAG-3 |
Payment date | Validity (years) | Amount | |
2023-05-23 | 7 | 162.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-06-20 |